Storia di Donna

Stiamo trasformando in realtà le opzioni personalizzate
con il kit di sonde Vysis ALK Break Apart FISH
Guarda la storia completa (4:05 min.)

Vieni a conoscere Donna

Nel 2007, una biopsia rivela a Donna Gaidamak di avere un cancro al polmone al quarto stadio che ha metastatizzato al cervello. Donna viene così sottoposta al test per il riarrangiamento del gene ALK con il kit di sonde Vysis ALK Break Apart FISH di Abbott. I risultati dimostrano che è positiva all'ALK ed è immediatamente messa sotto terapia con XALKORI®(crizotinib). Oggi, Donna è di nuovo in grado di svolgere le attività che ama: andare in bici, sciare, fare kayak e andare in barca a vela.

 
 
           

  

Kit di sonde Vysis ALK Break Apart FISHProdotto correlato

Destinazione d'uso

Il kit di sonde Vysis ALK Break Apart FISH rileva i riarrangiamenti che coinvolgono il gene ALK attraverso la tecnologia di ibridazione fluorescente in situ (FISH) in campioni di tessuto di cancro del polmone non a piccole cellule (NSCLC) fissati in formalina e inclusi in paraffina (FFPE).

Visualizza dettagli prodotto 

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No